Immunosuppression for HCV following liver transplantation: enough is just enough

Affiliations

¹ Morrow Gastroenterology and Liver Centre, Australian Liver Transplant Unit, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. gmccaughan@centenary.usyd.edu.au

Comment

G W McCaughan. Transplantation. 2004.

. 2004 Nov 27;78(10):1413-4.

doi: 10.1097/01.tp.0000140976.61265.61.

¹ Morrow Gastroenterology and Liver Centre, Australian Liver Transplant Unit, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. gmccaughan@centenary.usyd.edu.au

No abstract available

Comment on

Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.
Filipponi F, Callea F, Salizzoni M, Grazi GL, Fassati LR, Rossi M, Risaliti A, Burra P, Agnes S, De Carlis L, Valente U, Ferrara R, Pisati R. Filipponi F, et al. Transplantation. 2004 Nov 27;78(10):1488-95. doi: 10.1097/01.tp.0000140881.07208.4e. Transplantation. 2004. PMID: 15599313 Clinical Trial.